Elizabeth McKenna: The May issue of Cancer Discovery
Elizabeth McKenna shared on LinkedIn:
“The May issue of Cancer Discovery is now online!
The cover features work by Doug Rubinson, Noritaka Tanaka, Andrew Aguirre, Ryan Corcoran, and colleagues showing that sotorasib is a pan-RAS G12C inhibitor capable of driving clinical response in NRAS G12C cancers.
Also in this issue: a commentary on spatial biology by Cameron Walker and Michael Angelo and a review on AI in oncology by Bill Lotter, Michael Hassett, Nikolaus Schultz, Ken Kehl, Eliezer Van Allen and Ethan Cerami that were inspired by AACR24 plenary sessions, and much more.
Source: Elizabeth McKenna/LinkedIn
Elizabeth McKenna is the Executive Director of Cancer Discovery at the American Association for Cancer Research. Elizabeth earned her PhD from Harvard University and trained with Dr. Charles Roberts at the Dana-Farber Cancer Institute.
Her research was among the first to show that pediatric tumors characterized by mutations in chromatin remodelers are genomically stable and instead driven by epigenetic deregulation of key target genes.
She joined Cancer Discovery shortly after its launch as its founding Science Writer and became an editor in 2014, rising through the editorial ranks to become the journal’s Executive Editor in 2019. She is a member of the 40 Under 40 in Cancer Class of 2021.
